Rapport Therapeutics

RAPPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.183 B

$45.49 -1.85%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$111.5M

Loss-making

Shares outstanding

47,978,286

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#107Braveheart BioBRVE$2.20B
#108HUTCHMED (China)HCM$2.18B
#109Rapport TherapeuticsRAPP$2.18B
#110Stoke TherapeuticsSTOK$2.11B
#111GH ResearchGHRS$2.08B

Where these numbers come from

Share counts and financials for Rapport Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.